Jinying Wei
Impact in
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
Papers in
-
- Peroxisome Proliferator-Activated Receptors 3
- Redox biology and oxidative stress 3
- Metabolism, Diabetes, and Cancer 2
-
- Chronic Kidney Disease and Diabetes 3
- Renal Diseases and Glomerulopathies 2
- Co-authors
- Huijun Duan (13 shared papers)Haijiang Wu (13 shared papers)Yonghong Shi (9 shared papers)Chunyang Du (8 shared papers)Yunzhuo Ren (8 shared papers)Yanjuan Hou (5 shared papers)Ming Wu (7 shared papers)Xinna Deng (4 shared papers)
- Journals
- Drug Design Development and Therapy (2 papers)Biochemical and Biophysical Research Communications (1 paper)Oxidative Medicine and Cellular Longevity (1 paper)PLoS ONE (1 paper)Archives of Gynecology and Obstetrics (1 paper)
- Partner nations
- ChinaCanadaSaudi Arabia
In The Last Decade
Jinying Wei
21 papers receiving 650 citations
Peers
Comparison fields: 5 of 74
- Nephrology 117
- Clinical Biochemistry 82
- Biochemistry 39
- Physiology 120
- Endocrinology, Diabetes and Metabolism 74
Countries citing papers authored by Jinying Wei
This map shows the geographic impact of Jinying Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinying Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinying Wei more than expected).
Fields of papers citing papers by Jinying Wei
This network shows the impact of papers produced by Jinying Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinying Wei. The network helps show where Jinying Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Jinying Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 130 | |
| 2 | 2015 | 106 | |
| 3 | 2013 | 69 | |
| 4 | 2018 | 56 | |
| 5 | 2015 | 48 | |
| 6 | 2016 | 43 | |
| 7 | 2015 | 41 | |
| 8 | 2015 | 30 | |
| 9 | 2020 | 28 | |
| 10 | 2019 | 27 | |
| 11 | 2015 | 21 | |
| 12 | 2021 | 15 | |
| 13 | 2017 | 15 | |
| 14 | 2020 | 8 | |
| 15 | 2023 | 5 | |
| 16 | 2023 | 4 | |
| 17 | [High fat diet induced the expression of SREBP-1, TGF-beta1 and alpha-SMA in renal tubular cells and extracellular matrix accumulation in Wistar rats]. | 2010 | 4 |
| 18 | 2023 | 2 | |
| 19 | Melatonin Protects against Primary Ovarian Insufficiency by Activating the PI3K/Akt/mTOR Pathway and Inhibiting Autophagy. | 2022 | 2 |
| 20 | 2024 | 1 |
About Jinying Wei
Jinying Wei is a scholar working on Molecular Biology, Nephrology, Clinical Biochemistry, Cell Biology and Physiology, having authored 22 papers that have together received 656 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (4 papers), Chronic Kidney Disease and Diabetes (3 papers), Endoplasmic Reticulum Stress and Disease (3 papers), Adipose Tissue and Metabolism (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Redox biology and oxidative stress (3 papers), Metabolism, Diabetes, and Cancer (2 papers) and Renal Diseases and Glomerulopathies (2 papers). The work is most often cited by research in Nephrology (117 citations), Clinical Biochemistry (82 citations), Biochemistry (39 citations), Physiology (120 citations) and Endocrinology, Diabetes and Metabolism (74 citations). Jinying Wei has collaborated with scholars based in China, Canada and Saudi Arabia. Frequent co-authors include Huijun Duan, Haijiang Wu, Yonghong Shi, Chunyang Du, Yunzhuo Ren, Yanjuan Hou, Ming Wu, Xinna Deng, Yonghong Shi and Shuangcheng Li. Their work appears in journals such as Drug Design Development and Therapy, Biochemical and Biophysical Research Communications, Oxidative Medicine and Cellular Longevity, PLoS ONE and Archives of Gynecology and Obstetrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.